Clicks Group Limited (CLCGY)
USD 40.95
(-1.09%)
USD 40.95
(-1.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 5.99 Billion ZAR | 14.9% |
| 2023 | 5.22 Billion ZAR | 10.26% |
| 2022 | 4.75 Billion ZAR | 13.21% |
| 2021 | 4.12 Billion ZAR | 4.55% |
| 2020 | 4.04 Billion ZAR | 43.9% |
| 2019 | 3.6 Billion ZAR | 15.77% |
| 2018 | 2.39 Billion ZAR | 13.42% |
| 2017 | 2.11 Billion ZAR | 15.17% |
| 2016 | 1.83 Billion ZAR | 11.84% |
| 2015 | 1.63 Billion ZAR | 13.5% |
| 2014 | 1.45 Billion ZAR | 10.01% |
| 2013 | 1.31 Billion ZAR | 10.21% |
| 2012 | 1.19 Billion ZAR | 8.53% |
| 2011 | 1.09 Billion ZAR | 13.78% |
| 2010 | 970.35 Million ZAR | 15.29% |
| 2009 | 831.06 Million ZAR | 18.93% |
| 2008 | 723.45 Million ZAR | 25.17% |
| 2007 | 565.36 Million ZAR | 12.27% |
| 2006 | 465.31 Million ZAR | 9.88% |
| 2005 | 431.32 Million ZAR | 67.38% |
| 2004 | 249.85 Million ZAR | -44.16% |
| 2003 | 456.58 Million ZAR | 16.24% |
| 2002 | 421.87 Million ZAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 175.45 Million USD | 0.0% |
| 2024 Q2 | 144.07 Million USD | 103.22% |
| 2023 FY | - ZAR | 10.26% |
| 2023 Q4 | 148.49 Million USD | 0.0% |
| 2023 Q2 | 135.91 Million USD | 0.0% |
| 2022 FY | - ZAR | 13.21% |
| 2022 Q4 | 177.2 Million USD | 0.0% |
| 2022 Q2 | 144.75 Million USD | 0.0% |
| 2021 Q4 | 148.38 Million USD | 0.0% |
| 2021 Q2 | 127.22 Million USD | 0.0% |
| 2021 FY | - ZAR | 4.55% |
| 2020 Q4 | 122.54 Million USD | 0.0% |
| 2020 Q2 | 122.91 Million USD | 0.0% |
| 2020 FY | - ZAR | 43.9% |
| 2019 FY | - ZAR | 15.77% |
| 2019 Q4 | 102.86 Million USD | 0.0% |
| 2018 FY | - ZAR | 13.42% |
| 2017 FY | - ZAR | 15.17% |
| 2016 FY | - ZAR | 11.84% |
| 2015 FY | - ZAR | 13.5% |
| 2014 FY | - ZAR | 10.01% |
| 2013 FY | - ZAR | 10.21% |
| 2012 FY | - ZAR | 8.53% |
| 2011 FY | - ZAR | 13.78% |
| 2010 FY | - ZAR | 15.29% |
| 2009 FY | - ZAR | 18.93% |
| 2008 FY | - ZAR | 25.17% |
| 2007 FY | - ZAR | 12.27% |
| 2006 FY | - ZAR | 9.88% |
| 2005 FY | - ZAR | 67.38% |
| 2004 FY | - ZAR | -44.16% |
| 2003 FY | - ZAR | 16.24% |
| 2002 FY | - ZAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | 2385862471.072% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | 2477958.198% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | -6601.42% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 423413.498% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | 12492570.495% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | 469880.139% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | -12584.491% |
| MedGen, Inc. | -15.37 USD | 38979434062.264% |
| Omni Health, Inc. | 1.28 Million USD | -465195.768% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | 1741882.327% |
| Pineapple, Inc. | -1.47 Million USD | 406202.375% |
| ScripsAmerica, Inc. | -3.95 Million USD | 151603.034% |